USPTO serial 76374498
BIOTEST
Reviewed by CopyMark Law Group
Reg. 2961650Status 710
- Filing date
- Status date
- Registration date
- Jun 14, 2005
- Examiner
- EDWARDS, ALICIA COLLINS
- Law office
- —
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with BIOTEST?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
60528 Frankfurt/Main, DE
60528 Frankfurt/Main, DE
Dreieich, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John W. McGlynn
John W. McGlynn RATNERPRESTIA1007 Orange Street, Suite 1100P.O. BOX 1596Wilmington, DE 19899Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ In-vitro diagnostic preparations for scientific purposes; test kits comprising reagents, sera, monoclonal and polyclonal antibodies, natural and recombinant antigens, and microtiter plates, and reagents for scientific and research purposes; systems for determining resistance for scientific purposes comprising nutrient media, cell culture media, and dried media; buffers, salts, solvents for research and scientific purposes; test kits comprising buffers, salts, solvents and reagents for industrial and scientific purposes for hygiene monitoring on surfaces, in air and liquids, and systems for identification of germs for scientific and research purposes comprising nutrient media, buffers and salts; DNA probes for tissue typing, germ or pathogen identification and blood group determination ] | SECTION 8 - CANCELLED | Oct 5, 1997 |
| 005 | [ Pharmaceutical and veterinary preparations and products for treating immune insufficiencies, especially autoimmune insufficiencies, cancer, virus infections, conditions of virus reactivation, anemia, protein anemia, immune globulin anemia, blood coagulation disorders, and deficiencies in blood coagulation factors, or for preventing rejections in transplantation medicine; food for babies; medical plasters; materials for wound, burn or surgical dressing; pharmaceutical preparations for hematology, oncology, transplantation medicine, nephrology, pediatrics, for intensive care medicine, namely, blood products, immune globulin preparations, globulin preparations, coagulation factors; medicines for use in transplantation procedures and for influencing blood coagulation; immune globulin preparations for treating immune insufficiencies, especially autoimmune insufficiencies, cancer, virus infections, conditions of virus reactivation, anemia, protein anemia, immune globulin anemia, blood coagulation disorders, and deficiencies in blood coagulation factors, or for preventing rejections in transplantation medicine; serum preparations, and serum proteins and solutions comprising the same for medical use; human albumin for medical use; blood products for medical use, namely, blood plasma; blood substitutes; plasma substitutes and plasma expanders; vaccines, especially on basis of immune globulines; blood coagulation preparations, especially coagulation factors for clinical and medical laboratory use; antibiotics; medicines for treating the central nervous system; medicines for treating heart and circulation diseases; medicines for treating the respiratory system; medicines for urological treatment; medicines for treatment of digestive organs and corresponding/adjoining glands; hormones; vitamins; immunosuppressive, anti-inflammatory, and antiallergic medicines; dermatological, ophtalmological and otological medicines; in-vivo and in-vitro diagnostic preparations for clinical or medical purposes and clinical or medical laboratory use; antibodies, namely, mono- and polyclonal antibodies for use in in-vivo clinical and medical diagnostics and for patient therapy; in vitro diagnostic agents for medical purposes, especially for determination of proteins, such as antibodies, monoclonal antibodies or immune globulins, or for determinations of nucleic acids, for blood group diagnostics and antibody determination, tissue typing, cell diagnostics, microbiological diagnostics, and determination of toxic compounds; test kits comprising ready to use nutrient media for microorganisms, especially bacteria, and reagents for medical and laboratory uses, especially for blood group diagnostics, antibody determination, tissue typing, cell diagnostics, microbiological diagnostics, determination of toxic substances; test kits comprising monoclonal and polyclonal antibodies and natural and recombinant antigenes, for tests on serological and immune genetic basis, and reagents therefore for human and veterinary medical laboratory purposes; immunoassays such as ELISA's, consisting of reagents, sera, monoclonal and polyclonal antibodies, natural and recombinant antigens, and microtiter plates, and reagents therefore for human and veterinary medical laboratory purposes; diagnostic preparations for human or veterinary medical uses in the treatment of infections; media for bacteriological cultures, namely, ready-to-use culture media and nutrient media and ingredients thereof ] | SECTION 8 - CANCELLED | Oct 5, 1997 |
| 009 | [ Plates and multiwell microtiter plates for cell typing, blood and virus diagnostics; blood warmers; apparatus, namely, incubator, cell sorter, cell counter, shaker, pipettes, plates and vials for cell recovery and for handling of cells, including disposable materials; ] measuring and surveying apparatus, namely, [ sample holder, reader, photometer, centrifuge, shaker, incubator, washer, particle counter ] and air sampler for removal, determination and quantification of microorganisms in air, [ liquids ] and on surfaces; [ measuring and surveying kits/systems and agar strips for determination and quantification of substances, namely, blood sugar, blood and respiratory alcohol, toxic substances, oxygen and blood constituents such as hemoglobin; ] kits/systems comprising agar strips, air samplers, [ particle counters, anemometers ] and agar strips for determination of air borne germs and for sanitary and hygiene monitoring, [ laboratory robot, for automated processing of microtiter plate based assays like ELISAs, DNA hybridization assays and cell agglutination tests; ] kits/systems comprising agar strips, air samplers, [ particle counters, anemometers ] and agar strips for determination of air borne germs and for determination of particle size and number in air; kits/systems comprising air samplers, sample holders and reader for clean room air monitoring; all the foregoing for use in research and/or non-medical laboratories | SECTION 8 - CANCELLED | Oct 5, 1977 |
| 010 | [ Medical, apparatus for clinical or diagnostic use, namely, apparatus for serological blood typing, blood grouping or serological detection of blood groups; bottles and containers specially designated for storage and conservation of solutions for transfusions and infusions; transfusion and infusion apparatus and devices, namely, containers, syringes, catheters, transdermal delivery systems comprising blood warmers and plasma for clinical use; apparatus for cell recovery and for handling of cells, including disposable materials, namely, plates, spatula, vials, pipette tips and beakers for clinical or diagnostic use; measuring and surveying apparatus for clinical and diagnostic use, namely, sample holder, reader, photometer, dipsticks, teststrips, and agar strips for determination and quantification of substances, especially blood sugar, blood and respiratory alcohol, toxic substances, oxygen and blood constituents such as hemoglobin; plates and multiwell microtiter plates for cell typing, blood and virus diagnostics for clinical and diagnostic use; all of the foregoing for medical, clinical, diagnostic and/or surgical use ] | SECTION 8 - CANCELLED | Oct 5, 1997 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BIOTEST AG
- Other trademarks owned by BIOTEST AG
- Other trademarks owned by BIOTEST AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named BIOTEST
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 15, 2016 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Jul 28, 2011 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED | — |
| Jul 27, 2011 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Jul 27, 2011 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jul 26, 2011 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 14, 2011 | 815F | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | — |
| Jun 14, 2011 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Nov 3, 2008 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 3, 2008 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 23, 2008 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Oct 23, 2008 | CANT | CANCELLATION TERMINATED NO. 999999 | — |
| Oct 23, 2008 | CAND | CANCELLATION DENIED NO. 999999 | — |
| Jan 6, 2008 | PETC | CANCELLATION INSTITUTED NO. 999999 | — |
| Jun 14, 2005 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 22, 2005 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 2, 2005 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 29, 2004 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 28, 2004 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 27, 2004 | ALIE | ASSIGNED TO LIE | — |
| Aug 25, 2004 | ALIE | ASSIGNED TO LIE | — |
| Aug 25, 2004 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Aug 24, 2004 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 7, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 7, 2004 | PAPER RECEIVED | — | |
| Feb 9, 2004 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 17, 2003 | CFIT | CASE FILE IN TICRS | — |
| Oct 20, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 20, 2003 | PAPER RECEIVED | — | |
| Apr 24, 2003 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 16, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 16, 2003 | PAPER RECEIVED | — | |
| Jul 18, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 14, 2002 | DOCK | ASSIGNED TO EXAMINER | — |